Elsevier,
eBioMedicine, Volume 94, August 2023
This Article supports Sustainable Development Goal 3 by identifying an independent relationship between anxiety and subsequent cognitive progression in older people without dementia; these findings suggest that treating anxiety and targeting mitochondrial dysfunction may be effective in preventing dementia.
Elsevier,
The Lancet Healthy Longevity, Volume 4, August 2023
This Article supports Sustainable Development Goal 3 by showing that although there was an increase in prescribing of antipsychotics to people with dementia during the COVID-19 pandemic, this increase was not responsible for the large increase in all-cause and stroke mortality in this population.
Elsevier,
The Lancet Regional Health - Southeast Asia, Volume 15, August 2023
Daily oral pre-exposure prophylaxis (PrEP) is effective in preventing HIV infection, MSM and TGW who exchange sex can have high PrEP uptake, persistence and adherence, and low HIV incidence when offered in supportive community-based settings.
Elsevier, The Lancet Regional Health - Western Pacific, Volume 37, August 2023
Background: Towards hepatitis C elimination among people who inject drugs (PWID), we assessed the effectiveness of a strategy consisting of a community-based respondent-driven sampling (RDS) as wide screening, a simplified and integrated hospital-based care, and prevention of reinfection supported by community-based organisations (CBO), in Hai Phong, Vietnam. Methods: Adults who injected heroin were enrolled in a RDS survey implemented in two CBO premises. Rapid HIV and HCV tests were done on site, and blood was taken for HCV RNA testing.
Elsevier,
The Lancet Regional Health - Europe, Volume 31, August 2023
This Comment supports SDGs 3 and 13 by highlighting the negative health impacts of climate change around the world and in Europe, and noting that populations most impacted by climate change tend to be the least responsible for contributing to it. The authors note that, like in the Global South, the most disadvantaged communities in Europe bear disproportionate burdens of negative health impacts of climate change, but that addressing this inequity is not currently an explicit goal of EU policies.
Elsevier,
The Lancet HIV, Volume 10, August 2023
This Article supports SDG 3 by showing that men who have sex with men (MSM) in Africa remain highly vulnerable to HIV acquisition and HIV-related mortality and morbidity, undermining the Global AIDS Strategy to end AIDS; realising the UNAIDS 95-95-95 targets and reducing disparities in HIV incidence requires urgent efforts to strengthen community-led prevention efforts.
Elsevier,
The Lancet Global Health, Volume 11, August 2023
This Article supports SDG 3 by showing that short-course tuberculosis preventive treatment is likely to be cost-effective (compared with no tuberculosis preventive treatment) for adult contacts in 15 countries and people living with HIV/AIDS in seven countries, even under conservative cost-effectiveness thresholds.
Elsevier,
The Lancet Regional Health - Europe, Volume 31, August 2023
This Article supports SDG 3 by focusing on pregnant and postpartum women with HIV and assessing the risk factors for adverse postpartum outcomes and examining which factors can be addressed to support breastfeeding in resource-rich settings.
Elsevier,
The Lancet Global Health, Volume 11, August 2023
This Article supports SDG 3 by examining cost-effectiveness of implementing the HITSystem, a web-based intervention designed to improve outcomes of infants exposed to HIV, in Kenya. The study finds that HITSystem is among the most cost-effective early infant diagnosis interventions reported to date; the the cost per infant exposed to HIV was US$31·38 and the incremental cost-effectiveness ratio for life-years saved was $82·72.
Elsevier,
The Lancet HIV, Volume 10, August 2023
This Article supports SDG 3 by highlighting the effectiveness of a new, multilevel service delivery model, including interventions at patient, provider, and clinic levels, that improves the virological outcomes of adolescents and young adults living with HIV, generalisable to the current treatment context in rural sub-Saharan Africa.
